Sarah Crandall-Fletcher
Nurse Practitioner · Charleston, WVNPI 1588672075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 680 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 29.8% of the total. Reporting peaked in 2022 at $2,819 and has fallen 71.7% since, to $797 in 2025. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 680 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$1K
- Ardelyx, Inc.$463
- Pfizer$459
- plus $3K from 24 others
What the payments were for
- Food & beverage$10,830100%
- Education$70%
- Gifts$290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 241 | $3,242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 108 | $1,679 |
| Takeda Pharmaceuticals U.S.A., Inc. | 78 | $1,171 |
| Johnson & Johnson | 51 | $1,137 |
| Ardelyx, Inc. | 27 | $463 |
| Pfizer | 27 | $459 |
| Sanofi | 18 | $436 |
| Redhill Biopharma Inc. | 22 | $293 |
| Intercept Pharmaceuticals, Inc. | 16 | $271 |
| QOL Medical, LLC | 14 | $235 |
| Gilead | 16 | $231 |
| Regeneron Healthcare Solutions, Inc. | 7 | $156 |
| Bristol Myers Squibb | 9 | $147 |
| Merck | 7 | $111 |
| Nestle Healthcare Nutrition Inc. | 1 | $110 |
| Celltrion USA Inc. | 4 | $107 |
| Madrigal Pharmaceuticals | 5 | $93 |
| Braintree Laboratories, Inc. | 5 | $87 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
| Novo Nordisk | 4 | $63 |
| Evoke Pharma, Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Axonics, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $30 |
| Amgen | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Corcept Therapeutics | 1 | $25 |
| AstraZeneca | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$110
How this compares
$10,866 in reported general payments places this provider in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $177,104 |
| LinzessLinaclotide | 119 | $137,875 |
| IbsrelaTenapanor Hcl | 53 | $134,813 |
| CreonLipase/Protease/Amylase | 34 | $125,548 |
| ZenpepLipase/Protease/Amylase | 14 | $62,261 |
| Mesalamine ErMesalamine | 126 | $51,504 |
| Colestipol Hcl | 155 | $28,743 |
| Mesalamine | 21 | $19,249 |
| Mesalamine DrMesalamine | 27 | $11,625 |
| Lubiprostone | 61 | $11,230 |
| Dexlansoprazole DrDexlansoprazole | 17 | $6,285 |
| MovantikNaloxegol Oxalate | 12 | $4,872 |
| Balsalazide Disodium | 21 | $4,603 |
| Famotidine | 382 | $4,024 |
| Esomeprazole Magnesium | 87 | $3,755 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $3,242 | $263,423153 claims |
| Ardelyx, Inc.Ibsrela | $463 | $134,81353 claims |
| Aimmune Therapeutics, Inc.Zenpep | $85 | $62,26114 claims |
| Redhill Biopharma Inc.Movantik | $293 | $4,87212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Charleston
- Monica HigginbothamCharleston$5K
- Jessica UedaCharleston$4K
- Monica ArmstrongCharleston$4K
- Wendy LeeberCharleston$3K
- Jamie StonerCharleston$3K
- Teresa GoodsonCharleston$3K
- Lindsey DavisCharleston$2K
- Leigh BrooksPrinceton$75K
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.